Bank Of New York Mellon Corp Tg Therapeutics, Inc. Transaction History

Bank Of New York Mellon Corp

$538 Trillion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$5.01 - $11.83 $2.49 Million - $5.87 Million	496,597 New	496,597 $5.87 Million
Q3 2022 Nov 14, 2022	BUY	$4.57 - $8.4 $238,101 - $437,648	52,101 Added 13.07%	450,877 $2.67 Million
Q2 2022 Aug 15, 2022	SELL	$3.74 - $10.66 $498,459 - $1.42 Million	-133,278 Reduced 25.05%	398,776 $1.7 Million
Q1 2022 May 11, 2022	SELL	$7.81 - $20.45 $367 - $961	-47 Reduced 0.01%	532,054 $5.06 Million
Q4 2021 Feb 11, 2022	SELL	$15.2 - $35.51 $499,730 - $1.17 Million	-32,877 Reduced 5.82%	532,101 $10.1 Million
Q3 2021 Nov 12, 2021	BUY	$21.78 - $40.45 $716,082 - $1.33 Million	32,878 Added 6.18%	564,978 $18.8 Million
Q2 2021 Aug 11, 2021	BUY	$32.5 - $48.96 $715,585 - $1.08 Million	22,018 Added 4.32%	532,100 $20.6 Million
Q1 2021 May 13, 2021	SELL	$41.61 - $54.3 $760,048 - $991,843	-18,266 Reduced 3.46%	510,082 $24.6 Million
Q4 2020 Feb 09, 2021	BUY	$25.27 - $54.9 $1.57 Million - $3.41 Million	62,031 Added 13.3%	528,348 $27.5 Million
Q3 2020 Nov 12, 2020	BUY	$18.49 - $27.24 $563,926 - $830,792	30,499 Added 7.0%	466,317 $12.5 Million
Q2 2020 Aug 12, 2020	BUY	$8.9 - $21.84 $648,970 - $1.59 Million	72,918 Added 20.09%	435,818 $8.49 Million
Q1 2020 May 06, 2020	BUY	$7.14 - $15.99 $273,533 - $612,576	38,310 Added 11.8%	362,900 $3.57 Million
Q4 2019 Feb 14, 2020	BUY	$5.1 - $11.2 $75,995 - $166,891	14,901 Added 4.81%	324,590 $3.6 Million
Q3 2019 Nov 07, 2019	SELL	$5.38 - $8.99 $7,074 - $11,821	-1,315 Reduced 0.42%	309,689 $1.74 Million
Q2 2019 Aug 12, 2019	BUY	$6.27 - $8.65 $185,761 - $256,273	29,627 Added 10.53%	311,004 $2.69 Million
Q1 2019 May 14, 2019	BUY	$4.02 - $8.04 $12,393 - $24,787	3,083 Added 1.11%	281,377 $2.26 Million
Q4 2018 Feb 11, 2019	SELL	$3.44 - $5.76 $29,408 - $49,242	-8,549 Reduced 2.98%	278,294 $1.14 Million
Q3 2018 Nov 09, 2018	BUY	$5.15 - $14.0 $54,167 - $147,252	10,518 Added 3.81%	286,843 $0
Q2 2018 Aug 06, 2018	BUY	$12.5 - $15.0 $362,650 - $435,180	29,012 Added 11.73%	276,325 $3.63 Million
Q1 2018 May 15, 2018	BUY	$8.7 - $16.8 $12,675 - $24,477	1,457 Added 0.59%	247,313 $3.51 Million
Q4 2017 Feb 09, 2018	BUY	$7.35 - $12.3 $1.81 Million - $3.02 Million	245,856	245,856 $2.02 Million

Others Institutions Holding TGTX

# of Institutions

345

Shares Held

87.6M

Call Options Held

2.35M

Put Options Held

1.7M

Vanguard Group Inc Valley Forge, PA

15.4M
Shares

$515 Million
0.01% of portfolio
Black Rock Inc. New York, NY

11.4M
Shares

$381 Million
0.0% of portfolio
State Street Corp Boston, MA

9.09M
Shares

$304 Million
0.01% of portfolio
Pictet Asset Management Holding Sa Carouge, V8

3.58M
Shares

$120 Million
0.1% of portfolio
Geode Capital Management, LLC Boston, MA

3.21M
Shares

$107 Million
0.01% of portfolio

View Full List

About TG THERAPEUTICS, INC.

Ticker TGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 145,274,000
Market Cap $4.86B
Description
TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...

More about TGTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Account